TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC
TCRCure Biopharma Ltd.
TCRCure Biopharma Ltd.
Fate Therapeutics
Genocea Biosciences, Inc.
PharmaMar
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Northwestern University
National Cancer Institute (NCI)
Cancer Research UK